Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Personal Finance Center Mortgages Loans Investing & Retirement Spending & Savings

Calculators

401k Retirement Calculator Mortgage Calculator

Compound Interest Calculator Dollar Cost Averaging

Student Loan Calculator Auto Loan Calculator

Education

How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks TipRanks Community Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Top Online Brokers Become an Affiliate

Follow Us

News Smart Portfolio Expert Center TipRanksAI

TOOLS

Earnings Calendar

Daily Analyst Ratings

STOCKS

ADVANCED RESEARCH

TipRanks Premium

Invest Like a Pro with Unique Data & Simplifed ToolsTry Now

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Plans & Pricing

Education

How To Use TipRanks

About Us

TipRanks Community

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

Follow Us

EMMLF

OKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease

Press ReleasesOKYO Pharma Announces Randomized Segment Now Underway in Phase 2 Clinical Trial of Topical Ocular OK-101 for Dry Eye Disease

$OKYO Pharma Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023$

PremiumPress Releases

OKYO Pharma Announces Presentations at the American Society of Cataract and Refractive Surgery (ASCRS 2023) in San Diego, CA, May 5-8, 2023

1y ago

OKYO Pharma screens first patient for OK-101 trial

PremiumThe Fly

OKYO Pharma screens first patient for OK-101 trial

1y ago

OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease

PremiumPress Releases

OKYO Pharma Announces First-Patient First-Visit for Phase 2 Trial Evaluating Efficacy and Safety of OK-101 in Patients with Dry Eye Disease

1y ago

OKYO Pharma activates first OK-101 clinical trial site in the U.S.

PremiumThe Fly

OKYO Pharma activates first OK-101 clinical trial site in the U.S.

1y ago

OKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease

PremiumPress ReleasesOKYO Pharma Announces Activation of First Clinical Trial Site in the U.S. for the Phase 2 Trial Evaluating OK-101 for the Treatment of Dry Eye Disease

1y ago

Notice of General Meeting and Publication of Circular

PremiumPress Releases

Notice of General Meeting and Publication of Circular

1y ago

British Market Update: Stronger Pound Pulls the FTSE Down; Rathbones-Investec Deal

PremiumGlobal Markets

British Market Update: Stronger Pound Pulls the FTSE Down; Rathbones-Investec Deal

1y ago

OKYO Pharma to delist from London Stock Exchange

PremiumThe Fly

OKYO Pharma to delist from London Stock Exchange

1y ago

Notice of Intention to Delist From The London Stock Exchange

PremiumPress Releases

Notice of Intention to Delist From The London Stock Exchange

1y ago

OKYO Pharma chairman purchases 11,000 ADS for $1.41

PremiumThe Fly

OKYO Pharma chairman purchases 11,000 ADS for $1.41

1y ago

OKYO Pharma Today Announces Director Acquires Shares

PremiumPress Releases

OKYO Pharma Today Announces Director Acquires Shares

1y ago

OKYO Pharma chairman purchases 12,500 ADS for $1.32

PremiumThe FlyOKYO Pharma chairman purchases 12,500 ADS for $1.32

1y ago

OKYO Pharma Today Announces Director Acquires Shares

PremiumPress Releases

OKYO Pharma Today Announces Director Acquires Shares

1y ago

OKYO Pharma Announces PDMR Dealing

PremiumPress Releases

OKYO Pharma Announces PDMR Dealing

1y ago

OKYO Pharma announces OK-101 trial listed on ClinicalTrials.gov public website

PremiumThe Fly

OKYO Pharma announces OK-101 trial listed on ClinicalTrials.gov public website

1y ago

OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website

PremiumPress Releases

OKYO Pharma Announces Phase 2 Trial of OK-101 Drug to Treat Dry Eye Disease is now listed on the ClinicalTrials.gov Public Website

1y ago

OKYO Pharma to issue 3.503M ADSs at $1.50 in private placement

PremiumThe Fly

OKYO Pharma to issue 3.503M ADSs at $1.50 in private placement

1y ago

OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management

PremiumPress Releases

OKYO Pharma Limited announces U.S.$5.74 million Global Private Placement and investment by directors and members of senior management

1y ago

OKYO Pharma Limited Prices $5.3 Million Offering of ADSs

PremiumPress ReleasesOKYO Pharma Limited Prices $5.3 Million Offering of ADSs

1y ago

OKYO Pharma announces OK-101 clears customs in the U.S.

PremiumThe Fly

OKYO Pharma announces OK-101 clears customs in the U.S.

1y ago

OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to Its Scientific Advisory Board

PremiumPress Releases

OKYO Pharma Announces Appointment of Dr. Jay S. Pepose to Its Scientific Advisory Board

1y ago

Trending

S&P 500

Dow Jones

Nasdaq 100

More Trending Stocks >